BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 9613636)

  • 1. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.
    Johnson JL; Vjecha MJ; Okwera A; Hatanga E; Byekwaso F; Wolski K; Aisu T; Whalen CC; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1998 May; 2(5):397-404. PubMed ID: 9613636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
    Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
    East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of pulmonary infections in predominantly HIV-infected adults with suspected tuberculosis, Botswana.
    Lockman S; Hone N; Kenyon TA; Mwasekaga M; Villauthapillai M; Creek T; Zell E; Kirby A; Thacker WL; Talkington D; Moura IN; Binkin NJ; Clay L; Tappero JW
    Int J Tuberc Lung Dis; 2003 Aug; 7(8):714-23. PubMed ID: 12921146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Okwera A; Nsubuga P; Nakibali JG; Whalen CC; Hom D; Cave MD; Yang ZH; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1032-40. PubMed ID: 11092715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chest radiography and beta-2-microglobulin levels in HIV-seronegative and HIV-seropositive African patients with pulmonary tuberculosis.
    Richter C; Pallangyo KJ; Ndosi BN; Chum HJ; Swai AB; Shao J
    Trop Geogr Med; 1994; 46(5):283-7. PubMed ID: 7855913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of tuberculosis associated with HIV infection in Taiwan.
    Hsieh SM; Hung CC; Chen MY; Chang SC; Hsueh PR; Luh KT; Chuang CY
    J Formos Med Assoc; 1996 Dec; 95(12):923-8. PubMed ID: 9000809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of sputum smear-positive tuberculosis patients with and without HIV infection in a hospital in Zimbabwe.
    Schoch OD; Rieder HL
    Eur Respir J; 1996 Feb; 9(2):284-7. PubMed ID: 8777965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F; Mahan CS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures.
    Pepper T; Joseph P; Mwenya C; McKee GS; Haushalter A; Carter A; Warkentin J; Haas DW; Sterling TR
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):397-403. PubMed ID: 18371265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.
    Chamie G; Luetkemeyer A; Walusimbi-Nanteza M; Okwera A; Whalen CC; Mugerwa RD; Havlir DV; Charlebois ED
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1295-302. PubMed ID: 20843421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence.
    Samb B; Sow PS; Kony S; Maynart-Badiane M; Diouf G; Cissokho S; Bâ D; Sané M; Klotz F; Faye-Niang MA; Mboup S; Ndoye I; Delaporte E; Hane AA; Samb A; Coulaud JP; Coll-Seck AM; Larouzé B; Murray JF
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):330-6. PubMed ID: 10206504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation.
    Batungwanayo J; Taelman H; Dhote R; Bogaerts J; Allen S; Van de Perre P
    Am Rev Respir Dis; 1992 Jul; 146(1):53-6. PubMed ID: 1626814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.